Esperion Therapeutics
ESPR
#6734
Rank
ยฃ0.38 B
Marketcap
ยฃ1.97
Share price
2.49%
Change (1 day)
107.84%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of November 2024 (TTM): 1.75

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.41. At the end of 2024 the company had a P/S ratio of 1.51.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.51-48.2%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
8.83 403.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.39 150.73%๐Ÿ‡บ๐Ÿ‡ธ USA
2.56 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA
5.91 237.24%๐Ÿ‡บ๐Ÿ‡ธ USA
6.23 255.59%๐Ÿ‡บ๐Ÿ‡ธ USA
76.6 4,273.20%๐Ÿ‡บ๐Ÿ‡ธ USA